Dystonia-associated mutations cause premature degradation of torsinA protein and cell-type-specific mislocalization to the nuclear envelope

被引:65
作者
Giles, Lisa M. [1 ]
Chen, Jue [1 ]
Li, Lian [1 ]
Chin, Lih-Shen [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1093/hmg/ddn173
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An in-frame 3 bp deletion in the torsinA gene resulting in the loss of a glutamate residue at position 302 or 303 (torsinA Delta E) is the major cause for early-onset torsion dystonia (DYT1). In addition, an 18 bp deletion in the torsinA gene resulting in the loss of residues 323-328 (torsinA Delta 323-8) has also been associated with dystonia. Here we report that torsinA Delta E and torsinA Delta 323-8 mutations cause neuronal cell-type-specific mislocalization of torsinA protein to the nuclear envelope without affecting torsinA oligomerization. Furthermore, both dystonia-associated mutations destabilize torsinA protein in dopaminergic cells. We find that wild-type torsinA protein is degraded primarily through the macroautophagy-lysosome pathway. In contrast, torsinA Delta E and torsinA Delta 323-8 mutant proteins are degraded by both the proteasome and macroautophagy-lysosome pathways. Our findings suggest that torsinA mutation-induced premature degradation may contribute to the pathogenesis of dystonia via a loss-of-function mechanism and underscore the importance of both the proteasome and macroautophagy in the clearance of dystonia-associated torsinA mutant proteins.
引用
收藏
页码:2712 / 2722
页数:11
相关论文
共 68 条
[51]   The AAA team: related ATPases with diverse functions [J].
Patel, S ;
Latterich, M .
TRENDS IN CELL BIOLOGY, 1998, 8 (02) :65-71
[52]   Molecular defects of the dystonia-causing torsinA mutation [J].
Pham, Phuong ;
Frei, Karen P. ;
Woo, William ;
Truong, Daniel D. .
NEUROREPORT, 2006, 17 (16) :1725-1728
[53]   c-fos mRNA expression in rat cortical neurons during glutamate-mediated excitotoxicity [J].
Rogers, A ;
Schmuck, G ;
Scholz, G ;
Williams, DC .
TOXICOLOGICAL SCIENCES, 2004, 82 (02) :562-569
[54]   TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion [J].
Rostasy, K ;
Augood, SJ ;
Hewett, JW ;
Leung, JCO ;
Sasaki, H ;
Ozelius, LJ ;
Ramesh, V ;
Standaert, DG ;
Breakefield, XO ;
Hedreen, JC .
NEUROBIOLOGY OF DISEASE, 2003, 12 (01) :11-24
[55]   The roles of intracellular protein-degradation pathways in neurodegeneration [J].
Rubinsztein, David C. .
NATURE, 2006, 443 (7113) :780-786
[56]  
Sambrook J., 1989, MOL CLONING LAB MANU, V2nd ed.
[57]   3-METHYLADENINE - SPECIFIC INHIBITOR OF AUTOPHAGIC LYSOSOMAL PROTEIN-DEGRADATION IN ISOLATED RAT HEPATOCYTES [J].
SEGLEN, PO ;
GORDON, PB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (06) :1889-1892
[58]   Immunohistochemical localization and distribution of torsinA in normal human and rat brain [J].
Shashidharan, P ;
Kramer, BC ;
Walker, RH ;
Olanow, CW ;
Brin, MF .
BRAIN RESEARCH, 2000, 853 (02) :197-206
[59]   Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated ΔE-torsinA mutant [J].
Torres, GE ;
Sweeney, AL ;
Beaulieu, JM ;
Shashidharan, P ;
Caron, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (44) :15650-15655
[60]   AAA proteins: Lords of the ring [J].
Vale, RD .
JOURNAL OF CELL BIOLOGY, 2000, 150 (01) :F13-F19